CME Group Inc (NASDAQ:CME) has been assigned a consensus rating of “Buy” from the sixteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $157.00.
CME has been the subject of a number of research analyst reports. Bank of America lifted their price target on CME Group from $173.00 to $175.00 and gave the stock a “buy” rating in a report on Friday, February 2nd. Zacks Investment Research upgraded CME Group from a “hold” rating to a “buy” rating and set a $164.00 price objective for the company in a report on Tuesday, January 2nd. Sandler O’Neill restated a “buy” rating and set a $175.00 price objective on shares of CME Group in a report on Friday, February 2nd. Barclays boosted their price objective on CME Group from $170.00 to $175.00 and gave the stock an “overweight” rating in a report on Friday, February 2nd. Finally, BidaskClub upgraded CME Group from a “buy” rating to a “strong-buy” rating in a report on Saturday, February 10th.
Shares of CME Group (CME) traded down $2.73 during trading on Wednesday, reaching $162.38. The company had a trading volume of 1,448,900 shares, compared to its average volume of 1,703,312. The firm has a market cap of $55,260.00, a P/E ratio of 37.07, a PEG ratio of 2.10 and a beta of 0.64. CME Group has a twelve month low of $114.82 and a twelve month high of $165.35. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.03 and a quick ratio of 1.05.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 26th. Investors of record on Friday, March 9th will be paid a $0.70 dividend. This is a boost from CME Group’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Thursday, March 8th. This represents a $2.80 annualized dividend and a dividend yield of 1.72%. CME Group’s payout ratio is currently 60.27%.
In other news, Director Ronald A. Pankau sold 200 shares of the company’s stock in a transaction dated Wednesday, February 14th. The shares were sold at an average price of $159.91, for a total transaction of $31,982.00. Following the transaction, the director now owns 3,809 shares in the company, valued at $609,097.19. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Derek Sammann sold 2,400 shares of the company’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $161.66, for a total transaction of $387,984.00. Following the transaction, the insider now owns 40,153 shares in the company, valued at approximately $6,491,133.98. The disclosure for this sale can be found here. Insiders have sold 64,728 shares of company stock worth $9,755,257 in the last ninety days. Insiders own 0.57% of the company’s stock.
Several institutional investors and hedge funds have recently bought and sold shares of CME. OLD Mutual Customised Solutions Proprietary Ltd. grew its position in shares of CME Group by 50.5% during the 4th quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 18,190 shares of the financial services provider’s stock valued at $2,657,000 after acquiring an additional 6,100 shares during the period. Slow Capital Inc. bought a new position in shares of CME Group during the 4th quarter valued at approximately $448,000. Banco de Sabadell S.A bought a new position in shares of CME Group during the 4th quarter valued at approximately $1,994,000. Lake Street Advisors Group LLC bought a new position in shares of CME Group during the 4th quarter valued at approximately $624,000. Finally, MetLife Investment Advisors LLC bought a new position in CME Group in the 4th quarter worth approximately $15,377,000. Institutional investors own 82.63% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Analysts Set CME Group Inc (CME) Price Target at $157.00” was first reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this article on another site, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The correct version of this article can be viewed at https://stocknewstimes.com/2018/02/19/analysts-set-cme-group-inc-cme-price-target-at-157-00.html.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.